EP Wealth Advisors LLC Takes $212,000 Position in Avanos Medical, Inc. (NYSE:AVNS)

EP Wealth Advisors LLC acquired a new position in shares of Avanos Medical, Inc. (NYSE:AVNS) in the third quarter, HoldingsChannel.com reports. The institutional investor acquired 8,819 shares of the company’s stock, valued at approximately $212,000.

Several other institutional investors have also recently modified their holdings of the stock. Paradice Investment Management LLC grew its holdings in Avanos Medical by 5.4% during the 2nd quarter. Paradice Investment Management LLC now owns 1,344,949 shares of the company’s stock valued at $26,791,000 after buying an additional 69,389 shares during the last quarter. Foundry Partners LLC lifted its position in shares of Avanos Medical by 1.1% in the third quarter. Foundry Partners LLC now owns 163,030 shares of the company’s stock valued at $3,918,000 after acquiring an additional 1,800 shares in the last quarter. AQR Capital Management LLC boosted its stake in shares of Avanos Medical by 21.0% during the second quarter. AQR Capital Management LLC now owns 146,983 shares of the company’s stock valued at $2,875,000 after acquiring an additional 25,467 shares during the last quarter. FMR LLC increased its position in Avanos Medical by 34.6% during the 3rd quarter. FMR LLC now owns 133,844 shares of the company’s stock worth $3,216,000 after purchasing an additional 34,421 shares in the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its stake in Avanos Medical by 12.0% in the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 108,470 shares of the company’s stock valued at $2,607,000 after purchasing an additional 11,613 shares during the last quarter. 95.17% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Separately, StockNews.com cut shares of Avanos Medical from a “strong-buy” rating to a “buy” rating in a research note on Sunday, November 3rd.

Avanos Medical Stock Down 2.5 %

AVNS stock opened at $17.97 on Friday. Avanos Medical, Inc. has a one year low of $17.39 and a one year high of $25.36. The stock has a market capitalization of $825.90 million, a P/E ratio of 52.85 and a beta of 0.95. The company has a 50 day moving average price of $20.27 and a two-hundred day moving average price of $21.43. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.46 and a current ratio of 2.22.

About Avanos Medical

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.